Hydrogenated starch hydrolysate
General Information
| Mainterm | Hydrogenated starch hydrolysate |
| CAS Reg.No.(or other ID) | 68425-17-2 |
| Regnum |
From www.fda.gov
Computed Descriptors
Download SDF| 2D Structure | |
| CID | 91932559 |
| IUPAC Name | (2S,4R,5R)-4-[(2R,3R,4R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxyhexane-1,2,3,5,6-pentol |
| InChI | InChI=1S/C18H34O16/c19-1-5(23)9(25)15(6(24)2-20)33-18-14(30)12(28)16(8(4-22)32-18)34-17-13(29)11(27)10(26)7(3-21)31-17/h5-30H,1-4H2/t5-,6+,7+,8?,9?,10+,11-,12+,13+,14+,15+,16?,17+,18+/m0/s1 |
| InChI Key | XJCCHWKNFMUJFE-LHGMTSDLSA-N |
| Canonical SMILES | C(C1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC(C(CO)O)C(C(CO)O)O)CO)O)O)O)O |
| Molecular Formula | C18H34O16 |
From Pubchem
Computed Properties
| Property Name | Property Value |
|---|---|
| Molecular Weight | 506.454 |
| Hydrogen Bond Donor Count | 12 |
| Hydrogen Bond Acceptor Count | 16 |
| Rotatable Bond Count | 11 |
| Complexity | 598.0 |
| CACTVS Substructure Key Fingerprint | A A A D c f B 4 P g A A A A A A A A A A A A A A A A A A A A A A A A A k S A A A A A A A A A A A A A A A G g A A C A A A C B S w g A M A C A A A B g A A A A A A A A A A A A A A A A A A A A A A A A A R E A I A A A A i Q A A F A A A H A A H A Y A w A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
| Topological Polar Surface Area | 280.0 |
| Monoisotopic Mass | 506.185 |
| Exact Mass | 506.185 |
| XLogP3 | None |
| XLogP3-AA | -7.4 |
| Compound Is Canonicalized | True |
| Formal Charge | 0 |
| Heavy Atom Count | 34 |
| Defined Atom Stereocenter Count | 11 |
| Undefined Atom Stereocenter Count | 3 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Isotope Atom Count | 0 |
| Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-Brain Barrier | BBB+ | 0.5297 |
| Human Intestinal Absorption | HIA- | 0.8480 |
| Caco-2 Permeability | Caco2- | 0.8886 |
| P-glycoprotein Substrate | Substrate | 0.5191 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7260 |
| Non-inhibitor | 0.9089 | |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8502 |
| Distribution | ||
| Subcellular localization | Mitochondria | 0.6424 |
| Metabolism | ||
| CYP450 2C9 Substrate | Non-substrate | 0.8449 |
| CYP450 2D6 Substrate | Non-substrate | 0.8853 |
| CYP450 3A4 Substrate | Non-substrate | 0.6647 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9631 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9621 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9379 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9398 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9683 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9472 |
| Excretion | ||
| Toxicity | ||
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9594 |
| Non-inhibitor | 0.8020 | |
| AMES Toxicity | Non AMES toxic | 0.9304 |
| Carcinogens | Non-carcinogens | 0.9560 |
| Fish Toxicity | Low FHMT | 0.8653 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.6981 |
| Honey Bee Toxicity | High HBT | 0.6597 |
| Biodegradation | Not ready biodegradable | 0.6059 |
| Acute Oral Toxicity | IV | 0.5607 |
| Carcinogenicity (Three-class) | Non-required | 0.6764 |
From admetSAR
ADMET Predicted Profile --- Regression
| Model | Value | Unit |
|---|---|---|
| Absorption | ||
| Aqueous solubility | -0.2021 | LogS |
| Caco-2 Permeability | -0.7588 | LogPapp, cm/s |
| Distribution | ||
| Metabolism | ||
| Excretion | ||
| Toxicity | ||
| Rat Acute Toxicity | 1.1640 | LD50, mol/kg |
| Fish Toxicity | 2.3810 | pLC50, mg/L |
| Tetrahymena Pyriformis Toxicity | -0.4043 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organic oxygen compounds |
| Class | Organooxygen compounds |
| Subclass | Carbohydrates and carbohydrate conjugates |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Oligosaccharides |
| Alternative Parents | |
| Molecular Framework | Aliphatic heteromonocyclic compounds |
| Substituents | Oligosaccharide - Fatty acyl glycoside - Alkyl glycoside - Glycosyl compound - O-glycosyl compound - Fatty alcohol - Fatty acyl - Sugar alcohol - Oxane - Secondary alcohol - Organoheterocyclic compound - Acetal - Oxacycle - Polyol - Alcohol - Hydrocarbon derivative - Primary alcohol - Aliphatic heteromonocyclic compound |
| Description | This compound belongs to the class of organic compounds known as oligosaccharides. These are carbohydrates made up of 3 to 10 monosaccharide units linked to each other through glycosidic bonds. |
From ClassyFire